Pfizer and Allergan to Combine With Joint Value of $160 BillionBy and
Price is 27% premium to Allergan shares before talks public
Read to be CEO, Saunders to be president of new Pfizer Plc
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.